Percutaneous Heart Valve Articles & Analysis: Older
8 news found
Leslie Miller, Chief Medical Officer whom will be presenting the update at the ASAIO Annual Meeting Second Heart Assist designed this long term chronic device with specific intent to help serve the Class III heart failure patients for which there are no percutaneous (non surgical) delivered mechanical solutions available today. Up to a dozen ...
The Second Heart Assist abstract will be published in the ASAIO Journal and will be a citable reference. ...
During that time period we took that same stent, put a heart valve in the middle, and patented the very first percutaneous heart valve system that was also sold to Medtronic. ...
The consistency in the clinical results demonstrated through the enrollment of patients receiving multiple sizes of the Colibri TAVI System, soon to be complimented with the addition of a 21mm and 30mm size, demonstrate the scalability in the Colibri valve and TAVI System design.” The ongoing EFS will enroll up to 10 individuals with severe aortic stenosis, who will be ...
Colibri Heart Valve LLC, a privately held emerging medical device company, today announced that the first two patients have been successfully enrolled in a clinical early feasibility study (EFS) of the company’s disruptive second-generation ready-for-use balloon-expandable transcatheter aortic valve implantation (TAVI) system. ...
Colibri Heart Valve, LLC, a privately held medical device company, has been granted yet another patent directed to prosthetic heart valves. ...
Colibri Heart Valve LLC, a privately held emerging medical device company, has received notification from the European Patent Office that patent application No. 11751242.6 titled, “Percutaneously Deliverable Heart Valve and Methods Associated Therewith” has been granted and is expected to publish as ...
Patent No. 9,125,739 (the “’739 Patent”) titled, “Percutaneous Replacement Heart Valve and a Delivery and Implantation ...